
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Q1FY26 Financial Results Marksans Pharma ₹620 Cr Revenue in Q1 FY26, up 5% YoY; Strong Cash Position of ₹711 Cr Supports Growth Initiatives".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated August 12, 2025, titled "Q1FY26 Financial Results Marksans Pharma ₹620 Cr Revenue in Q1 FY26, up 5% YoY; Strong Cash Position of ₹711 Cr Supports Growth Initiatives".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma